Publicación en la Editorial REDLIC
Estimados investigadores:
Nos complace anunciar que contamos con las siguientes vacantes en el Catálogo de Prensa.
1. Editores de sección [7]
2. Editores asociados [10]
Contemporary research from a multidisciplinary vision. : Book 6. Health Sciences
Keywords:
diabetes insipidus syndrome, polycystic ovary syndrome, diabetes mellitus, pancreatitis, vaccine, papillomavirus, human papilloma, cancer, cervix, ketoacidosis, complicationsSynopsis
Prologue
The cutting edge of Health Sciences research is defined not only by its ability to respond to current challenges, but also by its audacity in entering complex and not yet fully understood areas. "Contemporary Research from a Multidisciplinary Vision. Book 6. Health Sciences" continues this tradition of excellence and exploration, consolidating itself as a pillar of advanced knowledge. This volume is committed to illuminating pragmatic solutions to persistent problems in the field of health and advancing the understanding of critical issues.
The result of exceptional collaboration between prominent authors and the Latin American Editorial Network for Contemporary Research, this book transcends the boundaries of conventional knowledge. It reaffirms the commitment to academic excellence and innovation, reflecting the unwavering dedication to the highest scientific standards. The Network has played a crucial role in the conception, development and publication of this work, ensuring that each contribution stands out for its quality and originality.
This volume is distinguished by its commitment to the democratization of knowledge. Following the tradition of the series, all chapters are available for free download under a Creative Commons license, thus facilitating universal access to the latest advances in Health Sciences. This effort is possible thanks to the platform of the Latin American Editorial Network for Contemporary Research, which serves as an invaluable resource for researchers, health professionals and the general public interested in the subject.
Each chapter has been subjected to a rigorous editorial process, including an exhaustive anti-plagiarism check and a review by external blind peers. This guarantees not only the quality and originality of the information presented, but also the reliability of the conclusions. The topics addressed in this book, from neurogenic dehydration and diabetes insipidus to the effectiveness of the HPV vaccine in preventing cervical cancer, are testament to the multidisciplinary approach and depth of contemporary health research.
In a further step towards international accessibility and visibility, each chapter and the book as a whole have been assigned a Digital Object Identifier (DOI) by Crossref. This unique and permanent identifier facilitates citation and academic access worldwide, ensuring the durability of each contribution in the vast landscape of scientific research.
We invite students, healthcare professionals, and anyone interested in the latest research in Health Sciences to explore this volume. Its content not only offers answers to current questions, but also expands understanding of the management and diagnosis of complex conditions, thus contributing to the advancement of medicine and human well-being.
This book is a tribute to the tireless efforts of its authors, whose commitment to academic excellence and the pursuit of knowledge has resulted in a work that enriches our understanding of contemporary Health Sciences. We also extend our gratitude to the editors and the Ecuadorian Book Chamber for their essential support in the realization and dissemination of this important contribution to knowledge.
Red Editorial Latinoamericana de Investigación Contemporánea
Chapters
-
Capítulo 1: Deshidratación neurogénica: diabetes insípida - Revisión sistemática
-
Capítulo 2: Relación del síndrome de ovario poliquístico con la diabetes gestacional
-
Capítulo 3: Diabetes Mellitus tipo 3C causada por Pancreatitis
-
Capítulo 4: Efectividad de la vacuna del Virus del Papiloma Humano en la prevención del Cáncer Cervicouterino. Revisión sistemática
Downloads
Download data is not yet available.
References
Capítulo 1
Salas-Salvadó J, Maraver F, Rodríguez-Mañas L, Sáenz de Pipaón M, Vitoria I, Moreno LA, et al. Importancia del consumo de agua en la salud y la prevención de la enfermedad: situación actual. Nutrición Hospitalaria. octubre de 2020;37(5):1072-86.
Espinosa García MM, Daniel Guerrero AB, Durán Cárdenas C, Hernández Gutiérrez LS, Espinosa García MM, Daniel Guerrero AB, et al. Deshidratación en el paciente adulto. Revista de la Facultad de Medicina (México). febrero de 2021;64(1):17-25.
Contreras-Perusquía Y, Olivares-Schietekat S, Córdoba-Ostos E, Ahumada-Ayala M, Contreras-Perusquía Y, Olivares-Schietekat S, et al. Diabetes insípida central debida a histiocitosis de células de Langerhans. Medicina interna de México. agosto de 2019;35(4):638-45.
Mejorado Molano FJ, Soriano Guillén L. Diabetes insípida. Enfoque diagnóstico y terapéutico Diabetes insipidus. Diagnostic and therapeutic approach. Revista Española de Endocrinología Pediátrica. 8 de junio de 2021;12(2):11.
Jiménez CC, Vargas LFA. La sed ¿un mecanismo suficiente para lograr la hidratación?: una revisión narrativa. Pensar en Movimiento: Revista de Ciencias del Ejercicio y la Salud. 28 de marzo de 2023;21(1):e47939-e47939.
Christ-Crain M, Bichet DG, Fenske WK, Goldman MB, Rittig S, Verbalis JG, et al. Diabetes insipidus. Nat Rev Dis Primers. 8 de agosto de 2019;5(1):1-20.
Edmonds CJ, Foglia E, Booth P, Fu CHY, Gardner M. Dehydration in older people: A systematic review of the effects of dehydration on health outcomes, healthcare costs and cognitive performance. Archives of Gerontology and Geriatrics. 1 de julio de 2021;95:104380.
Lacey J, Corbett J, Forni L, Hooper L, Hughes F, Minto G, et al. A multidisciplinary consensus on dehydration: definitions, diagnostic methods and clinical implications. Annals of Medicine. 19 de mayo de 2019;51(3-4):232-51.
García Herrero MÁ, López de Soria CO, López Lois MG. Deshidratación aguda - Asociación Española de Pediatría. SEUP. 2020;17.
Montero D, Cheistwer A, Mirón L, Lorenzo J. Deshidratación. Revisión de terapia de rehidratación oral. Revista del Hospital de niños Ricardo Gutiérrez de Buenos Aires. 22 de octubre de 2019;1:8.
Pascual-Corrales E, Araujo-Castro M, Ortiz-Flores AE, Escobar-Morreale HF. Diabetes insípida. Medicine - Programa de Formación Médica Continuada Acreditado. 1 de octubre de 2020;13(18):993-9.
García García E. Diabetes insípida. AEP. 2019;14.
Serra Soler G, Antich Barceló C, García Fernández H. Diabetes insipidus and diabetes mellitus diagnosed at the same time in a male with Langerhans cell histiocytosis. Medicina Clínica (English Edition). 13 de agosto de 2021;157(3):152-3.
Tovar H, Flórez A, Quintero G, Concha D. Diabetes insípida de origen central secundario a hipofisitis. Reporte de 2 casos. Revista Colombiana de Endocrinología, Diabetes & Metabolismo. 2020;7(4):294-300.
Garrahy A, Thompson CJ. Management of central diabetes insipidus. Best Practice & Research Clinical Endocrinology & Metabolism. 1 de septiembre de 2020;34(5):101385.
García-Ruiz VR, Suárez-Rojas J, Álvarez-Gamero JC, Paz-Ibarra JL. [Adipsic diabetes insipidus patient in postoperative pituitary macroadenoma]. Rev Med Inst Mex Seguro Soc. 4 de noviembre de 2020;58(6):740-5.
Corredor Andrés B, Muñoz Calvo MT, López Pino MÁ, Márquez Rivera M, Travieso Suárez L, Pozo Román J, et al. Engrosamiento del tallo hipofisario en niños y adolescentes con diabetes insípida central: causas y consecuencias. Anales de Pediatría. 1 de mayo de 2019;90(5):293-300.
Ramírez-Guerrero G, Müller-Ortiz H, Pedreros-Rosales C. Poliuria en el adulto. Una aproximación diagnóstica basada en la fisiopatología. Revista Clínica Española. 1 de mayo de 2022;222(5):301-8.
Corredor Andrés B, Muñoz Calvo MT, López Pino MÁ, Márquez Rivera M, Travieso Suárez L, Pozo Román J, et al. [Thickening of the pituitary stalk in children and adolescents with central diabetes insipidus: Causes and consequences]. An Pediatr (Engl Ed). mayo de 2019;90(5):293-300.
Ruiz-Sánchez JG, Parra Ramírez P, Martín Rojas-Marcos P, Lecumberri Santamaría B, Álvarez Escolá C. In-patient management protocol for diabetes insipidus associated with adipsia. Developed from a clinical case. Endocrinol Diabetes Nutr. 1 de noviembre de 2021;68(9):668-70.
Tomkins M, Lawless S, Martin-Grace J, Sherlock M, Thompson CJ. Diagnosis and Management of Central Diabetes Insipidus in Adults. The Journal of Clinical Endocrinology & Metabolism. 1 de octubre de 2022;107(10):2701-15.
Christ-Crain M, Winzeler B, Refardt J. Diagnosis and management of diabetes insipidus for the internist: an update. Journal of Internal Medicine. 2021;290(1):73-87.
Thadhani RI, Maynard S. Polyuria and diabetes insipidus of pregnancy - Uptodate Free. 16 de septiembre de 2022 [citado 5 de julio de 2024]; Disponible en: https://pro.uptodatefree.ir/Show/115441
Spiess M, Beuret N, Rutishauser J. Genetic forms of neurohypophyseal diabetes insipidus. Best Practice & Research Clinical Endocrinology & Metabolism. 1 de septiembre de 2020;34(5):101432.
Capítulo 2
Escobar H, Bayona A, Nattero L, Luque M. 1. Diabetes mellitus tipo 1 y síndrome de ovario poliquístico | Nature Reviews Endocrinología. 2021 [citado 6 de mayo de 2024];17. Disponible en: https://www.nature.com/articles/s41574-021-00576-0
Yan Q, Qiu D, Liu X, Xing Q, Liu R, Hu Y. 2. The incidence of gestational diabetes mellitus among women with polycystic ovary syndrome: a meta-analysis of longitudinal studies. BMC Pregnancy Childbirth. 29 de abril de 2022;22(1):370. https://pubmed.ncbi.nlm.nih.gov/35488240/
Otta CF, Ramos N, Carlo MD, Dicuatro N, Iraci G. 3. Fenotipos del síndrome de ovario poliquístico y su asociación con diabetes gestacional. Rev Soc Argent Diabetes. 30 de agosto de 2023;57(3Sup):44-44. https://dialnet.unirioja.es/servlet/articulo?codigo=9507314
Shiguango N, Morocho A, Guerrero P, Goyes M, Chicaiza Á, Guamancuri J, et al. 4. Determinación de factores de riesgo para diabetes gestacional. Diabetes Int Endocrinol [Internet]. 2022 [citado 16 de junio de 2024];14(1). Disponible en: http://saber.ucv.ve/ojs/index.php/rev_di/article/view/26399
Geraldine ANN. 5. FACTORES MATERNOS Y GINECO- OBSTÉTRICOS ASOCIADOS A LA APARICIÓN DE DIABETES GESTACIONAL EN EL HOSPITAL NACIONAL HIPÓLITO UNANUE, AÑO 2015- 2018. [Internet]. [Perú]: San Juan Bautista; 2019. Disponible en: https://repositorio.upsjb.edu.pe/handle/20.500.14308/2116
Farland L, Stern J, Liu C, Cabral H, Coddington C, Diop H, et al. 6. Polycystic ovary syndrome and risk of adverse pregnancy outcomes: a registry linkage study from Massachusetts | Human Reproduction | Oxford Academic. 2022;37(11):2690-9. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627555/
Guixue G, Yifu P, Xiaofeng T, Qian S, Yuan G, Wen Y, et al. 7.Investigating the causal impact of polycystic ovary syndrome on gestational diabetes mellitus: a two-sample Mendelian randomization study. Front Endocrinol. 2024;15:1337562. https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2024.1337562/full
Mills G, Badeghiesh A, Suarthana E, Baghlaf H, Dahan M. 8. Human Reproduction | Oxford Academic. OUP Acad [Internet]. 2020 [citado 6 de mayo de 2024];35(7). Disponible en: https://academic.oup.com/humrep/humrep
Qiu Y, Zhang X, Ni Y. 9. Association between Polycystic Ovarian Syndrome and Risk of Gestational Diabetes Mellitus: A Meta-Analysis. Gynecol Obstet Invest. 16 de febrero de 2022;87(2):150-8.
Yang S, Yong S, Kim M, Seo Y, Yuk J. 10. JCM | Free Full-Text | Risk of Gestational Diabetes and Pregnancy-Induced Hypertension with a History of Polycystic Ovary Syndrome: A Nationwide Population-Based Cohort Study. 2023 [citado 6 de mayo de 2024];12(5). Disponible en: https://www.mdpi.com/2077-0383/12/5/1738
Barbieri R, Erhmann D. Uptodate. 2024 [citado 6 de mayo de 2024]. 11. Clinical manifestations of polycystic ovary syndrome in adults - UpToDate. Disponible en: https://www-uptodate-com.vpn.ucacue.edu.ec/contents/clinical-manifestations-of-polycystic-ovary-syndrome-in-adults?sectionName=IGT%2Ftype%202%20diabetes&search=Polycystic%20Ovary%20and%20Gestational%20Diabetes&topicRef=1771&anchor=H15&source=see_link#H15
Nokandeh OM, Nouri M, Mirzaei M, Mashak B, Mirmajidi R, Moghadam SB, et al. 12. Prevalence of diabetes in women with preeclampsia referred to Imam Hossein and Fatemieh Hospitals in Shahroud. Arch Venez Farmacol Ter. 2021;40(2):125-31. https://www.redalyc.org/journal/559/55969713004/html/
Zheng W, Huang W, Zhang L, Tian Z, Yan Q, Wang T, et al. 13. Early pregnancy metabolic factors associated with gestational diabetes mellitus in normal-weight women with polycystic ovary syndrome: a two-phase cohort study | Diabetology & Metabolic Syndrome. 2019 [citado 6 de mayo de 2024];11(71). Disponible en: https://link.springer.com/article/10.1186/s13098-019-0462-6?fromPaywallRec=false
Fornes R, Simin J, Nguyen MH, Gonzalo Cruz, Crisosto N, van der Schaaf, et al. 16. Pregnancy, perinatal and childhood outcomes in women with and without polycystic ovary syndrome and metformin during pregnancy: a nationwide population-based study | Reproductive Biology and Endocrinology. 2022 [citado 6 de mayo de 2024];20(30). Disponible en: https://link.springer.com/article/10.1186/s12958-022-00905-6
Mansour A, Mirahmadd M, Mohaheri M, Jamalizadeh M, Hosseinimousa S, Rashidi F, et al. 19. Risk factors for insulin resistance related to polycystic ovarian syndrome in Iranian population | Scientific Reports. 2023 [citado 6 de mayo de 2024];13(10269). Disponible en: https://www.nature.com/articles/s41598-023-37513-2
Joham AE, Ranasinha S, Zoungas S, Moran L, Teede HJ. Gestational Diabetes and Type 2 Diabetes in Reproductive-Aged Women With Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 1 de marzo de 2014;99(3):E447-52. Gestational Diabetes and Type 2 Diabetes in Reproductive-Aged Women With Polycystic Ovary Syndrome https://pubmed.ncbi.nlm.nih.gov/24081730/
Chatzakis C, Tsakmaki E, Psomiadou A, Dinas K, Goulis D, Sotiriadis A. 21. Different pregnancy outcomes according to the polycystic ovary syndrome diagnostic criteria: a systematic review and meta-analysis of 79 studies - Fertility and Sterility. 2022 [citado 6 de mayo de 2024];117(854-881). Disponible en: https://www.fertstert.org/article/S0015-0282(21)02320-7/fulltext
Galicia C de JS, Lagunas PSR, Peregrino NR. Factores Asociados al Desarrollo de la Diabetes Gestacional en Pacientes Primigestas de 19 a 30 Años Atendidas en la Consulta Externa del Servicio de Ginecología y Obstetricia. Cienc Lat Rev Científica Multidiscip. 22 de marzo de 2024;8(1):7734-60.
Fuentes-Ibarra J, Valencia-Ortega J, González-Reynoso R, Saucedo R. 22. Síndrome de ovario poliquístico, más allá de una afección en la reproducción. Educ Salud Bol Científico Inst Cienc Salud Univ Autónoma Estado Hidalgo. 5 de diciembre de 2023;12(23):24-34. https://repository.uaeh.edu.mx/revistas/index.php/ICSA/article/view/10678
Risk of type 2 diabetes mellitus in polycystic ovary syndrome is associated with obesity: a meta-analysis of observational studies | Endocrine [Internet]. [citado 16 de junio de 2024]. Disponible en: https://link.springer.com/article/10.1007/s12020-021-02801-2
Ouyang P, Duan S, You Y, Jia X, Yang L. 14. Risk prediction of gestational diabetes mellitus in women with polycystic ovary syndrome based on a nomogram model. BMC Pregnancy Childbirth. 2 de junio de 2023;23(1):408. Risk prediction of gestational diabetes mellitus in women with polycystic ovary syndrome based on a nomogram model. BMC Pregnancy Childbirth. https://pubmed.ncbi.nlm.nih.gov/37268889/
Bayona A, Martínez-Vaello V, Zamora J, Nattero-Chávez L, Luque-Ramírez M, Escobar-Morreale HF. Prevalence of PCOS and related hyperandrogenic traits in premenopausal women with type 1 diabetes: a systematic review and meta-analysis. Hum Reprod Update. 1 de agosto de 2022;28(4):501-17. https://pubmed.ncbi.nlm.nih.gov/35237802/
Moreira Nieto D. 24. Síndrome de ovario poliquístico y riesgo de aborto. Revisión sistemática de la bibliografía y metaanálisis. 3 de junio de 2020 [citado 16 de junio de 2024]; Disponible en: http://addi.ehu.es/handle/10810/43737
Giménez-Osorio SR, Ríos-González CM, Giménez-Osorio SR, Ríos-González CM. 25. Características clínicas y epidemiológicas del Síndrome de Ovario Poliquístico en un Hospital de referencia de Paraguay. Rev Científica Cienc Salud. junio de 2020;2(1):18-26. https://pesquisa.bvsalud.org/portal/resource/pt/biblio-1292567
Livadas S, Anagnostis P, Bosdou JK, Bantouna D, Paparodis R. 26. Polycystic ovary syndrome and type 2 diabetes mellitus: A state-of-the-art review. World J Diabetes. 15 de enero de 2022;13(1):5-26. https://pubmed.ncbi.nlm.nih.gov/35070056/
Carvajal D, Vasquez M, Díaz S. 27. Diabetes Gestacional en Mujeres de América Latina: epidemiología y diagnóstico. MQRInvestigar. 24 de enero de 2023;7:852-93.
Aillón-Maroto I, Recalde-Navarrete R. 28. Actualización sobre el tratamiento de la infertilidad en el síndrome de ovario poliquístico SOP: Artículo de Revisión. Cienc Ecuad. 28 de agosto de 2023;5(22):1/19-1/19. https://cienciaecuador.com.ec/index.php/ojs/article/view/145
Fougner SL, Vanky E, Løvvik TS, Carlsen SM. 17. No impact of gestational diabetes mellitus on pregnancy complications in women with PCOS, regardless of GDM criteria used. PLOS ONE. 23 de julio de 2021;16(7):e0254895. https://pubmed.ncbi.nlm.nih.gov/34297751/
Nassif DS, Januário BL, Sousa BA, Thabane L, Abbade JF. 30. Effectiveness of metformin to pregnant women with PCOS to reduce spontaneous abortion and gestational diabetes mellitus: a protocol for an overview of reviews. BMJ Open. 25 de marzo de 2024;14(3):e078217.
Singh A, Aggarwal M, Garg R, Stevens T, Chahal P. 20. Post-pancreatitis diabetes mellitus: insight on optimal management with nutrition and lifestyle approaches - PubMed. 2022 [citado 2 de mayo de 2024];54(1). Disponible en: https://pubmed.ncbi.nlm.nih.gov/35786076/
Sánchez S. Las 7 partes del intestino: características y funciones [Internet]. 2021 [citado 18 de julio de 2021]. Disponible en: https://psicologiaymente.com/salud/partes-intestino
Capítulo 3
Narayanan S, Colton W, Jayaraman T, Yaser S, Jones CM. 1. Insuficiencia endocrina pancreática | Informes de Cirugía Actual. 2024;12:52-7.
Hamad A, Hyer JM, Thayaparan V, Salahuddin A, Cloyd JM, Pawlik TM, et al. 2. Pancreatogenic Diabetes after Partial Pancreatectomy: A Common and Understudied Cause of Morbidity. J Am Coll Surg. 1 de diciembre de 2022;235(6):838-45. https://pubmed.ncbi.nlm.nih.gov/36102556/
Sliwinska M, Milnerowicz S, Milnerowicz H. 3. Diabetes mellitus secondary to pancreatic diseases (type 3c): The effect of smoking on the exocrine-endocrine interactions of the pancreas - PubMed. 2018;15(3):243-59. https://pubmed.ncbi.nlm.nih.gov/29558826/
Jarlborg P, Jornayvaz FR. 22. Diabète pancréatoprive. Rev Med Suisse. 2022;18(784):1090-5. https://www.revmed.ch/revue-medicale-suisse/2022/revue-medicale-suisse-784/diabete-pancreatoprive
Umapathy C, Gajendran M, Mann R, Boregowda U, Theethira T, Elhanafi S, et al. Pancreatic fluid collections: Clinical manifestations, diagnostic evaluation and management. Dis Mon. 1 de noviembre de 2020;66(11):100986. https://www.sciencedirect.com/science/article/abs/pii/S0011502920300481
Jimenez-Luna C, Martin-Blazquez A, Dieguez-Castillo C, Díaz C, Martin-Ruiz JL, Genilloud O, et al. 24. Novel Biomarkers to Distinguish between Type 3c and Type 2 Diabetes Mellitus by Untargeted Metabolomics. Metabolites. 22 de octubre de 2020;10(11):423. https://pubmed.ncbi.nlm.nih.gov/33105675/
Zhou Y, Cao HW, Ji QH. 25. [Type 3C diabetes mellitus is an important subgroup of diabetes]. 1 de enero de 2021;60(1):9-12. https://www.researchgate.net/publication/348736166_Type_3C_diabetes_mellitus_is_an_important_subgroup_of_diabetes
Walker A, O’Kelly J, Graham C, Nowell S, Kidd D, Mole DJ. 13. Increased risk of type 3c diabetes mellitus after acute pancreatitis warrants a personalized approach including diabetes screening. BJS Open. 14 de diciembre de 2022;6(6):148. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749482/
Seguí Díaz M, Pérez Unanua MP, Peral Martínez I, López Serrano A, Aguirre Rodríguez JC. 15. La diabetes tipo 3c. Abordaje desde el médico del primer nivel. Med Fam SEMERGEN. 1 de noviembre de 2023;49(8):102074.
Arias RC, Gutiérrez JA, Gutiérrez AC. 26. Pancreatitis crónica en atención primaria: revisión bibliográfica. Rev Médica Sinerg [Internet]. 17 de agosto de 2022 [citado 2 de mayo de 2024];7(08). Disponible en: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=106844
Vonderau J, Desai C. 18. Type 3c: Understanding pancreatogenic diabetes : JAAPA. 2022;35(11):20-4.
Lin K, Yang X, Wu Y, Chen S, Zeng Q. 27. Corrigendum to «Residual β-Cell Function in Type 1 Diabetes Followed for 2 Years after 3C Study» - PubMed. 2021 [citado 2 de mayo de 2024]; Disponible en: https://pubmed.ncbi.nlm.nih.gov/34754883/
Capítulo 4
Cáncer de cuello uterino [Internet]. [citado 23 de mayo de 2024]. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/cervical-cancer.
Colón-López V, Ayala-Marín A, Vélez-Alamo C, Soto-Salgado M, Medina-Cortés L, Acevedo-Fontanez AI, et al. ¡Habla de VPH! An Educational Activity for College Students in Puerto Rico. P R Health Sci J. septiembre de 2021;40(3):142-6. PMID: 34792928.
Moleyar-Narayana P, Ranganathan S. Cancer Screening. En: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [citado 15 de mayo de 2024]. Disponible en: http://www.ncbi.nlm.nih.gov/books/NBK563138/
Bucheli DA, Hinojosa ASV, Trujillo ARH, Mora PGD. Carga de enfermedad por cáncer de cuello uterino en Ecuador, periodo 2015-2020. Metro Cienc. 30 de junio de 2022;30(2):10-7. DOI: https://doi.org/10.47464/MetroCiencia/vol30/2/2022/10-17
Williams Ginecología, 4e | AccessMedicina | McGraw Hill Medical [Internet]. [citado 14 de junio de 2024]. Disponible en: https://accessmedicina.mhmedical.com/book.aspx?bookID=2974
Vacuna contra el virus del papiloma humano (VPH) | OPS/OMS | Organización Panamericana de la Salud [Internet]. [citado 30 de mayo de 2024]. Disponible en: https://www.paho.org/es/vacuna-contra-virus-papiloma-humano-vph
Sendagorta-Cudós E, Burgos-Cibrián J, Rodríguez-Iglesias M. Infecciones genitales por el virus del papiloma humano. Enfermedades Infecc Microbiol Clínica. 1 de mayo de 2019;37(5):324-34. DOI: 10.1016/j.eimc.2019.01.010
Chan CK, Aimagambetova G, Ukybassova T, Kongrtay K, Azizan A. Human Papillomavirus Infection and Cervical Cancer: Epidemiology, Screening, and Vaccination-Review of Current Perspectives. J Oncol. 2019 Oct 10; 2019:3257939. doi: 10.1155/2019/3257939.
Bhatla N, Singhal S. Primary HPV screening for cervical cancer. Best Pract Res Clin Obstet Gynaecol. 2020 May; 65:98-108. doi: 10.1016/j.bpobgyn.2020.02.008.
Cervical cancer screening: Risk assessment, evaluation, and management after screening - UpToDate [Internet]. [citado 25 de marzo de 2024]. Disponible en: https://www-uptodate-com.vpn.ucacue.edu.ec/contents/cervical-cancer-screening-risk-assessment-evaluation-and-management-after-screening?search=genotipos+de+vph+&source=search_result&selectedTitle=1%7E40&usage_type=default&display_rank=1
Fernández Gracia Isabel, Cristóbal Ignacio, Neyro José Luis. Vacunas terapéuticas del virus del papiloma humano: revisión de la evidencia actual. Ginecol. obstet. Méx. [revista en la Internet]. 2020 [citado 2024 Jul 17]; 88(9): 615-624. DOI: https://doi.org/10.24245/gom.v88i9.4168.
Vega-Montero Willam A., Mercado-González Andrés F., Peralta-Cárdenas Marco V. Comparación de protocolos de vacunación contra el virus del papiloma humano en Ecuador y América Latina. Rev. chil. obstet. ginecol. [Internet]. 2023 Oct [citado 2024 Jul 17]; 88(5): 301-307. DOI: http://dx.doi.org/10.24875/rechog.22000120.
Vacuna contra el virus del papiloma humano previene cáncer uterino en el Ecuador – Ministerio de Salud Pública [Internet]. [citado 30 de mayo de 2024]. Disponible en: https://www.salud.gob.ec/vacuna-contra-el-virus-del-papiloma-humano-previene-cancer-uterino-en-el-ecuador/
Righolt CH, Bozat-Emre S, Mahmud SM. Effectiveness of school-based and high-risk human papillomavirus vaccination programs against cervical dysplasia in Manitoba, Canada. Int J Cancer. 2019 Aug 1;145(3):671-677. doi: 10.1002/ijc.32135.
Hernandez-Aguado JJ, Sánchez Torres DÁ, Martínez Lamela E, Aguión Gálvez G, Sanz Espinosa E, Pérez Quintanilla A, Martínez-Carrillo DA, Ramírez Mena M, Coronado Martín PJ, Zapardiel I, de la Fuente-Valero J. Quadrivalent Human Papillomavirus Vaccine Effectiveness after 12 Years in Madrid (Spain). Vaccines (Basel). 2022 Mar 3;10(3):387. doi: 10.3390/vaccines10030387.
Lei J, Ploner A, Elfström KM, Wang J, Roth A, Fang F, Sundström K, Dillner J, Sparén P. HPV Vaccination and the Risk of Invasive Cervical Cancer. N Engl J Med. 2020 Oct 1;383(14):1340-1348. doi: 10.1056/NEJMoa1917338.
Kjaer SK, Dehlendorff C, Belmonte F, Baandrup L. Real-World Effectiveness of Human Papillomavirus Vaccination Against Cervical Cancer. J Natl Cancer Inst. 2021 Oct 1;113(10):1329-1335. doi: 10.1093/jnci/djab080.
Johnson Jones ML, Gargano JW, Powell M, Park IU, Niccolai LM, Bennett NM, Griffin MR, Querec T, Unger ER, Markowitz LE; HPV-IMPACT Working Group. Effectiveness of 1, 2, and 3 Doses of Human Papillomavirus Vaccine Against High-Grade Cervical Lesions Positive for Human Papillomavirus 16 or 18. Am J Epidemiol. 2020 Apr 2;189(4):265-276. doi: 10.1093/aje/kwz253.
Markowitz LE, Naleway AL, Klein NP, Lewis RM, Crane B, Querec TD, Hsiao A, Aukes L, Timbol J, Weinmann S, Liu G, Steinau M, Unger ER. Human Papillomavirus Vaccine Effectiveness Against HPV Infection: Evaluation of One, Two, and Three Doses. J Infect Dis. 2020 Mar 2;221(6):910-918. doi: 10.1093/infdis/jiz555.
Rodriguez AM, Zeybek B, Vaughn M, Westra J, Kaul S, Montealegre JR, Lin YL, Kuo YF. Comparison of the long-term impact and clinical outcomes of fewer doses and standard doses of human papillomavirus vaccine in the United States: A database study. Cancer. 2020 Apr 15;126(8):1656-1667. doi: 10.1002/cncr.32700.
Brotherton JM, Budd A, Rompotis C, Bartlett N, Malloy MJ, Andersen RL, Coulter KA, Couvee PW, Steel N, Ward GH, Saville M. Is one dose of human papillomavirus vaccine as effective as three? A national cohort analysis. Papillomavirus Res. 2019 Dec; 8:100177. doi: 10.1016/j.pvr.2019.100177.
Palmer T, Wallace L, Pollock KG, Cuschieri K, Robertson C, Kavanagh K, et al. Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study. BMJ. 3 de abril de 2019;365: l1161. doi: https://doi.org/10.1136/bmj.l1161
Kudo R, Sekine M, Yamaguchi M, Hara M, Hanley SJB, Kurosawa M, Adachi S, Ueda Y, Miyagi E, Ikeda S, Yagi A, Enomoto T. Effectiveness of human papillomavirus vaccine against cervical precancer in Japan: Multivariate analyses adjusted for sexual activity. Cancer Sci. 2022 Sep;113(9):3211-3220. doi: 10.1111/cas.15471
Casajuana-Pérez A, Ramírez-Mena M, Ruipérez-Pacheco E, Gil-Prados I, García-Santos J, Bellón-Del Amo M, Hernández-Aguado JJ, de la Fuente-Valero J, Zapardiel I, Coronado-Martín PJ. Effectiveness of Prophylactic Human Papillomavirus Vaccine in the Prevention of Recurrence in Women Conized for HSIL/CIN 2-3: The VENUS Study. Vaccines (Basel). 2022 Feb 14;10(2):288. doi: 10.3390/vaccines10020288.
Thamsborg LH, Napolitano G, Larsen LG, Lynge E. High-grade cervical lesions after vaccination against human papillomavirus: A Danish cohort study. Acta Obstet Gynecol Scand. 2020 Oct;99(10):1290-1296. doi: 10.1111/aogs.13935.
Combita AL, Reyes V, Puerto D, Murillo R, Sánchez R, Nuñez M, Hernandez-Suarez GA, Wiesner C. Reduction in Vaccine HPV Type Infections in a Young Women Group (18-25 Years) Five Years after HPV Vaccine Introduction in Colombia. Cancer Prev Res (Phila). 2022 Jan;15(1):55-66. doi: 10.1158/1940-6207.CAPR-21-0063.
Ellingson MK, Sheikha H, Nyhan K, Oliveira CR, Niccolai LM. Human papillomavirus vaccine effectiveness by age at vaccination: A systematic review. Hum Vaccin Immunother. 2023 Aug 1;19(2):2239085. doi: 10.1080/21645515.2023.2239085.
Gargano JW, You M, Potter R, Alverson G, Swanson R, Saraiya M, Markowitz LE, Copeland G. An Evaluation of Dose-Related HPV Vaccine Effectiveness Using Central Registries in Michigan. Cancer Epidemiol Biomarkers Prev. 2022 Jan;31(1):183-191. doi: 10.1158/1055-9965.
Ozawa K, Hineno A, Kinoshita T, Ishihara S, Ikeda SI. Suspected Adverse Effects After Human Papillomavirus Vaccination: A Temporal Relationship Between Vaccine Administration and the Appearance of Symptoms in Japan. Drag Sal. 2017 Dec;40(12):1219-1229. dio: 10.1007/s40264-017-0574-6.
Capítulo 5
Dhatariya KK GNCEUG. Cetoacidosis diabética. Nat Rev Dis Cartillas. 2020 MAYO; 14;6(1):40. https://pubmed.ncbi.nlm.nih.gov/32409703/
Padilla Elizondo DS,CM,KP,&VFR. Manejo de la cetoacidosis diabética. Revista Médica Sinergia. 2022. https://revistamedicasinergia.com/index.php/rms/article/view/864
Glaser N FMPLRACVESWJCE. Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatr Diabetes. ISPAD clinical practice consensus guidelines 2022. 2022. https://pubmed.ncbi.nlm.nih.gov/36250645/
Belda Hofheinz S, del Villar Guerra P, Palacios Cuesta. Cetoacidosis diabética. elsevier.; Vol. 12.(Núm. 2.). https://www.elsevier.es/es-revista-anales-pediatria-continuada-51-articulo-cetoacidosis-diabetica-S1696281814701696
S. Malatesha G SNBARBGA. Comparison of arterial and venous pH, bicarbonate, PCO2 and PO2 in initial emergency department assessment. Emerg Med J. 2007. https://pubmed.ncbi.nlm.nih.gov/17652681/
Pérez-Nieto OR, Soto-Páramo DG, Rojas-Cruz, Vidal Mayo J, Zamarrón López El. Crisis Hiperglucémicas: Cetoacidosis Diabética y Estado Hiperosmolar Hiperglucémico. Critica! Care & Emergency Medicine. 2022. https://www.researchgate.net/publication/371366728_Crisis_Hiperglucemicas_Cetoacidosis_Diabetica_y_Estado_Hiperosmolar_Hiperglucemico_Hyperglycemic_Crises_Diabetic_Ketoacidosis_and_Hyperglycemic_Hyperosmolar_Syndrome_Narrative_Review_Revision_Narrativ
Fayfman M PFU. Management of hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state. Med Clin North Am. 2017. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535398/
Evans K. Diabetic ketoacidosis: update on management. Clinical Medicine. 2019. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771342/
Besen BAMP,ROT&SM. Management of diabetic ketoacidosis. Intensive Care Med. 2023. https://pubmed.ncbi.nlm.nih.gov/36166056/
Eledrisi MS, Elzouki AN. Management of Diabetic Ketoacidosis in Adults. Saudí Journal of Medicine and Medical Sciences. 2020. https://pubmed.ncbi.nlm.nih.gov/32952507/
KK D, British J. The management of diabetic ketoacidosis in adults-An updated guideline from the Joint British. Diabetes Societies for inpatient Care. https://pubmed.ncbi.nlm.nih.gov/35224769/
Andrade-Castellanos CA. Cetoacidosis diabética: puesta al día. Med lnt Méx. https://www.medigraphic.com/pdfs/medintmex/mim-2022/mim223o.pdf
Published
August 20, 2024
Copyright (c) 2024 María Teresa Durán Palacios, Andrés Sebastián Astudillo Ávila, Dennis Raúl Benavides Reinoso, Sergio Andrés Duchi Valdez, Luis Fernando Mora Ochoa, Nataly Cristina Peña Carrión, Deysi Maribel Toalongo Sucuzhañay, Germán Emilio Flores Barrera, Elton Cleber Mirandas Sposit, María Isabel Mora Vázquez, María Belén Gallegos Núñez, Emilio German Flores Barrera, María Isabel Mora Vázquez, Doménica Alexandra Heras Cisneros, María Belén Gallegos Núñez, Greinny Adamaries Rojas Reyes , German Emilio Flores Barrera
Details about the available publication format: Libro completo
Libro completo
ISBN-13 (15)
978-9942-659-07-1
Date of first publication (11)
2024-08-20
doi
10.58995/lb.redlic.40.257
Details about the available publication format: Capítulo 1
Capítulo 1
doi
10.58995/lb.redlic.40.258
Details about the available publication format: Capítulo 2
Capítulo 2
doi
10.58995/lb.redlic.40.259
Details about the available publication format: Capítulo 3
Capítulo 3
doi
10.58995/lb.redlic.40.260
Details about the available publication format: Capítulo 4
Capítulo 4
doi
10.58995/lb.redlic.40.261
Details about the available publication format: Capítulo 5
Capítulo 5
doi
10.58995/lb.redlic.40.262
